Endovia Health Sciences, Inc.
EDVANYSECIK 1553788Consumer staplesFiscal year ends Dec 31
Reports and events: 237 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-01-2710:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-000130 |
| 2026-01-2616:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001731122-26-000123 |
| 2025-12-2216:32 ET | S-1 | Registration statement | 0001731122-25-001709 |
| 2025-12-1816:26 ET | S-1 | Registration statement | 0001731122-25-001694 |
| 2025-12-1716:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001731122-25-001683 |
| 2025-12-1016:05 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001731122-25-001659 |
| 2025-11-1916:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001731122-25-001571 |
| 2025-11-1717:15 ET | 8-K/A | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001731122-25-001560 |
| 2025-11-1417:06 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001731122-25-001548 |
| 2025-11-0616:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001731122-25-001493 |
| 2025-10-3116:20 ET | SCHEDULE 13D | Ownership report, active investor | 0001731122-25-001463 |
| 2025-10-3016:50 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-25-001454 |
| 2025-10-2716:30 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001731122-25-001440 |
| 2025-10-2716:15 ET | SCHEDULE 13D | Ownership report, active investor | 0001731122-25-001438 |
| 2025-10-2117:13 ET | SCHEDULE 13D | Ownership report, active investor | 0001731122-25-001422 |
| 2025-10-2117:09 ET | SCHEDULE 13D | Ownership report, active investor | 0001731122-25-001421 |
| 2025-10-2116:35 ET | SCHEDULE 13D | Ownership report, active investor | 0001731122-25-001419 |
| 2025-10-2116:16 ET | SCHEDULE 13D | Ownership report, active investor | 0001731122-25-001417 |
| 2025-10-1716:16 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001731122-25-001401 |
| 2025-10-0617:12 ET | DEF 14A | Proxy statementPeriod 2025-10-06 | 0001731122-25-001357 |
| 2025-10-0116:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001731122-25-001337 |
| 2025-09-2516:24 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-25-001300 |
| 2025-09-0407:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001731122-25-001195 |
| 2025-08-1416:40 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001731122-25-001134 |
| 2025-08-0716:06 ET | DEF 14A | Proxy statementPeriod 2025-08-07 | 0001731122-25-001084 |
| 2025-07-3008:46 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-25-001051 |
| 2025-07-2913:15 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-25-001046 |
| 2025-07-1117:16 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001731122-25-000967 |
| 2025-07-1117:06 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001731122-25-000964 |
| 2025-06-2611:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-25-000912 |
| 2025-06-2610:31 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-25-000910 |
| 2025-06-1316:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001731122-25-000876 |
| 2025-04-1717:25 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001731122-25-000584 |
| 2025-04-1117:29 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-25-000569 |
| 2025-04-0317:48 ET | 8-K | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws | 0001731122-25-000508 |
| 2025-02-1217:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001731122-25-000211 |
| 2025-02-0416:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-25-000166 |
| 2024-12-0906:12 ET | S-1 | Registration statement | 0001731122-24-001951 |
| 2024-11-1816:16 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001731122-24-001825 |
| 2024-11-1517:26 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001731122-24-001822 |
| 2024-10-2216:12 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 2.04 Item not in the standard list; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001731122-24-001643 |
| 2024-10-1816:06 ET | DEF 14A | Proxy statementPeriod 2024-10-18 | 0001731122-24-001618 |
| 2024-08-2610:19 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001731122-24-001315 |
| 2024-08-1416:31 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001731122-24-001253 |
| 2024-08-0617:15 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001731122-24-001205 |
| 2024-07-0317:15 ET | DEF 14A | Proxy statementPeriod 2024-07-03 | 0001731122-24-001086 |
| 2024-06-1817:29 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-24-000967 |
| 2024-05-1517:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001731122-24-000818 |
| 2024-05-0717:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001731122-24-000753 |
| 2024-04-2617:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-24-000700 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 06:06 ET. Listed shows no prices and gives no investment advice.